Browsing: medicine
We’re familiar with the role of vaccines in preventatively treating conditions like measles and polio. But there’s a lot more…
This engaging book recounts how the deep problems in the current pharmaceutical and medical industries in the United States stem…
Cases of female breast cancer look set to to rise by 38% worldwide over the next 25 years, while deaths…
Meet the 56-year-old veterinarian who walked away from a 6-figure salary in the prime of her career because corporate ownership drove her to the nonprofit world
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…
The U.S. spends more on health care than any wealthy nation—but American lifespans are shorter. Here’s how the countries compare
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…
Mark Cuban’s $141K mistake: The Cost Plus Drugs cofounder says CEOs don’t understand health care coverage, and it’s costing them big
“Even though health insurance costs are the second-largest line item after payroll, CEOs don’t really understand it or know anything…
Over the past year, bird flu has spread far beyond America’s avian creatures. Largely concentrated among farm animals, it’s also…
Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows
Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in…
Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says
GLP-1s, or glucagon-like peptide-1 agonist drugs, are seemingly everywhere. In recent years, this class of weight-loss and Type 2 diabetes…
Zepbound vs. Wegovy: New clinical trial says this weight-loss medication sheds more pounds
Amid the war on obesity, a clear winner has emerged in a battle between two weight-loss injectables. Zepbound (tirzepatide), manufactured…











